• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Over-regulation partly to blame for ‘wildly expensive’ research costs, says medical executive

by February 14, 2025
written by February 14, 2025

While the debate over President Donald Trump’s cuts to facilities and administrative costs associated with federally funded research grants rages on, one expert in the field of medicine says he sees a clear way forward. 

Dr. David Skorton, president and CEO of the Association of American Medical Colleges, has had a wide-ranging career spanning government, higher education and medicine. He now runs a national association that oversees all Medical Doctorate-granting schools in the country, and about 500 academic health systems teaching hospitals. Skorton told Fox News Digital that while he does not agree with Trump’s blanket cuts, the current status quo needs changing. He cited over-regulation as a reason why facilities and administrative costs have gotten so ‘wildly expensive.’ 

He also said that transparency from research institutions could help create better awareness of how taxpayer dollars are being used to support those institutions that have become the bane of critics who say they are stockpiling taxpayer dollars for their own benefit. 

‘In some cases, more than one agency will develop regulations, and the researchers have to answer to all of those different agency regulations. We should be able to harmonize those things and come out with a more thoughtful approach to reducing some of the regulatory burden,’ Skorton said. He added that, in turn, researchers will be able to spend more time doing what they do best, research, which in the long run will mean greater results for the public.   

‘It would also mean that the costs would go down because the additional personnel, the additional things that are necessary to keep track of things for these regulations, that would also go down,’ Skorton pointed out.

Skorton said that the impact of reducing over-regulation will be two-fold: it will improve the current research environment and show that there is room for collaboration to reduce overhead costs while not threatening new research. In particular, he pointed to research involving human or animal subjects, which Skorton said is often riddled with regulatory requirements that, while important, could be streamlined.  

Skorton added that the AAMC was ‘very hungry’ to work with the administration on improving this framework, noting that ‘we’re not here to claim that the status quo is perfect, and we want to defend it, but the idea of very quickly knocking down the facilities and administrative costs to what felt like an arbitrary number to many of us, 15%, will cause research to be reduced.’

The AAMC president said there is an onus on research institutions as well to better educate folks about where their taxpayer dollars are going when they are utilized by federally funded research programs.

‘For every dollar that we get at universities, medical schools, et cetera, for research from the NIH or some other science agency, for every dollar another half dollar, roughly, is contributed by the institution,’ Skorton pointed out. ‘That’s something that maybe people don’t realize, and why would they, because we have to be more clear in making that visible, that we already contribute a lot to the research.’

Fox News Digital spoke to medical experts who have supported Trump’s blanket cut to administrative and facilities costs, and they argue that reducing this price burden on the federal government will increase the availability of new research grants, while getting rid of financial bloat that universities have been able to take advantage of at the taxpayers’ expense.

One of the doctors who shared their thoughts, Dr. Erika Schwartz, echoed calls for reform to the current structure, similar to Skorton.  

‘While infrastructure support is necessary, there’s room for more efficient cost management. A reformed funding model could redirect more resources to direct research activities while maintaining essential support services,’ Schwartz said. ‘This could potentially increase the number of funded research projects and accelerate medical breakthroughs, ultimately benefiting patients more directly.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump’s ‘two sexes’ order spurs state-level efforts to crack down on trans treatments for minors
next post
Federal judge delays Labor Department’s request to block DOGE access

related articles

SCOOP: Ilhan Omar hit with House Ethics complaint...

September 19, 2025

WATCH: Parody drug ad spotlights RFK’s crackdown on...

September 18, 2025

Hunter Biden was involved in pardon talks toward...

September 18, 2025

Senate confirms dozens of Trump nominees in first...

September 18, 2025

DC watchdog sues for docs on ‘modern-day Tuskegee...

September 18, 2025

Trump renews attacks on Biden autopen pardons, claims...

September 18, 2025

Schumer accuses Trump of exploiting Charlie Kirk’s death...

September 18, 2025

Turning Point USA elects Erika Kirk as new...

September 18, 2025

Trump: Putin has ‘really let me down’ on...

September 18, 2025

Trump administration asks Supreme Court to allow firing...

September 18, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • SafeMoon and Litecoin: LItecoin is approaching a new high

    August 15, 2024
  • Pete Marocco, mastermind behind dismantling of USAID projects, leaves State Department

    April 14, 2025
  • GGP Share Price Continues Decline. Will It Recover Soon?

    August 7, 2024
  • The Hitchhiker’s Guide to where we stand to avoid a government shutdown

    March 13, 2025
  • New poll reveals which Trump policies Americans love and hate

    February 12, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,081)
  • Investing (634)
  • Stock (927)

Latest Posts

  • Weeks after Epstein file fallout, a new deadline looms in the release of the RFK and MLK files

    March 9, 2025
  • Bondi says Epstein client list ‘sitting on my desk right now,’ and is reviewing JFK, MLK files

    February 21, 2025
  • White House silent on whether transcript of Biden’s ‘garbage’ comments was approved by stenographers

    October 31, 2024

Recent Posts

  • Tim Cook to join Trump at White House for Apple investment announcement

    August 7, 2025
  • Number of injunctions halting Trump policies trounces predecessors by double

    March 17, 2025
  • White House stands by tax bill after Musk calls it a ‘disgusting abomination’

    June 3, 2025

Editor’s Pick

  • Trump-backed bills on activist judges, non-citizen voting heading for House-wide votes

    April 8, 2025
  • Senate Republicans launch effort to ban Chinese nationals from buying land in US

    January 22, 2025
  • Failed VP candidate Tim Walz skewered after hinting at potential 2028 presidential run

    March 4, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock